The Effect of Vitamin D Supplementation on the Length of Hospitalisation, Intensive Care Unit Admission, and Mortality in COVID-19-A Systematic Review and Meta-Analysis

Overview

Journal Nutrients

Date 2023 Aug 12

PMID 37571407

Authors

Alexandru Constantin Sirbu

Octavia Sabin

Ioana Corina Bocsan

Stefan Cristian Vesa

Anca Dana Buzoianu

Affiliations

Soon will be listed here.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has become a global health crisis and pushed researchers and physicians to discover possible treatments to improve the outcome of their patients. Vitamin D, known for its role in immune system function, has been hypothesized to play a role in COVID-19 treatment. A systematic review and meta-analysis were conducted to evaluate the efficacy of vitamin D supplementation in COVID-19, focusing on length of hospital stay (LOS), admission to the intensive care unit (ICU), and mortality. Thirteen randomized controlled trials (RCTs) were included, and the meta-analysis revealed that high-dose vitamin D supplementation showed potential benefits in reducing the length of hospital stay and ICU admission rates for patients with COVID-19. However, the overall effect on mortality did not reach statistical significance. While this systematic review suggests the potential benefits of high-dose vitamin D supplementation in reducing hospital stays and ICU admission in COVID-19 patients, caution is warranted due to the high heterogeneity and limitations of the included studies. Further large-scale randomized controlled trials with consistent study characteristics are needed to provide more robust evidence regarding the therapeutic benefits of vitamin D supplementation in COVID-19 outcomes.

Citing Articles

Evaluation of Vitamin D Supplementation in Critically Ill Patients-A Narrative Review of Randomized Controlled Trials Published in the Last 5 Years.

Wang S, Ren R, Wang K, Leo C, Li M, Chow A Nutrients. 2025; 17(5).

PMID: 40077686 PMC: 11901431. DOI: 10.3390/nu17050816.

Vitamin D supplementations and mortality among patients with moderate/severe COVID-19: A meta-analysis of randomized controlled trials.

Mirghani H, Begum S J Res Med Sci. 2025; 29:68.

PMID: 39764224 PMC: 11702351. DOI: 10.4103/jrms.jrms_591_23.

COVID-19 in Children and Vitamin D.

Dura-Trave T, Gallinas-Victoriano F Int J Mol Sci. 2024; 25(22).

PMID: 39596272 PMC: 11594876. DOI: 10.3390/ijms252212205.

Vitamin D deficiency in Ukraine: A multicentre cross-sectional study.

Shatylo S, Bogomaz V, Babych O Glob Epidemiol. 2024; 8:100170.

PMID: 39483738 PMC: 11525160. DOI: 10.1016/j.gloepi.2024.100170.

The impact of supplementing vitamin D through different methods on the prognosis of COVID-19 patients: a systematic review and meta-analysis.

Zhang X, Wu J, Dong H, Shang N, Li Y, Zhang Y Front Nutr. 2024; 11:1441847.

PMID: 39385791 PMC: 11462671. DOI: 10.3389/fnut.2024.1441847.

References

Sutherland J, Zhou A, Hypponen E . Vitamin D Deficiency Increases Mortality Risk in the UK Biobank : A Nonlinear Mendelian Randomization Study. Ann Intern Med. 2022; 175(11):1552-1559. DOI: 10.7326/M21-3324. View

Li B, Yang S, Hou N . Could vitamin D supplementation play a role against COVID-19?. Front Immunol. 2022; 13:967215. PMC: 9511139. DOI: 10.3389/fimmu.2022.967215. View

Maghbooli Z, Sahraian M, Jamalimoghadamsiahkali S, Asadi A, Zarei A, Zendehdel A . Treatment With 25-Hydroxyvitamin D (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled,.... Endocr Pract. 2021; 27(12):1242-1251. PMC: 8511889. DOI: 10.1016/j.eprac.2021.09.016. View

Gunville C, Mourani P, Ginde A . The role of vitamin D in prevention and treatment of infection. Inflamm Allergy Drug Targets. 2013; 12(4):239-45. PMC: 3756814. DOI: 10.2174/18715281113129990046. View

McGrath S, Zhao X, Steele R, Thombs B, Benedetti A . Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis. Stat Methods Med Res. 2020; 29(9):2520-2537. PMC: 7390706. DOI: 10.1177/0962280219889080. View

Petrelli F, Luciani A, Perego G, Dognini G, Colombelli P, Ghidini A . Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies. J Steroid Biochem Mol Biol. 2021; 211:105883. PMC: 7997262. DOI: 10.1016/j.jsbmb.2021.105883. View

Sterne J, Savovic J, Page M, Elbers R, Blencowe N, Boutron I . RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019; 366:l4898. DOI: 10.1136/bmj.l4898. View

Torres M, Casado G, Vigon L, Rodriguez-Mora S, Mateos E, Ramos-Martin F . Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D. Biomed Pharmacother. 2022; 150:112965. PMC: 9008199. DOI: 10.1016/j.biopha.2022.112965. View

Annweiler C, Beaudenon M, Gautier J, Gonsard J, Boucher S, Chapelet G . High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial. PLoS Med. 2022; 19(5):e1003999. PMC: 9154122. DOI: 10.1371/journal.pmed.1003999. View

10.

Jolliffe D, Camargo Jr C, Sluyter J, Aglipay M, Aloia J, Ganmaa D . Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol. 2021; 9(5):276-292. DOI: 10.1016/S2213-8587(21)00051-6. View

11.

Martineau A, Jolliffe D, Hooper R, Greenberg L, Aloia J, Bergman P . Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017; 356:i6583. PMC: 5310969. DOI: 10.1136/bmj.i6583. View

12.

Hosseini B, El Abd A, Ducharme F . Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis. Nutrients. 2022; 14(10). PMC: 9147949. DOI: 10.3390/nu14102134. View

13.

Karonova T, Golovatyuk K, Kudryavtsev I, Chernikova A, Mikhaylova A, Aquino A . Effect of Cholecalciferol Supplementation on the Clinical Features and Inflammatory Markers in Hospitalized COVID-19 Patients: A Randomized, Open-Label, Single-Center Study. Nutrients. 2022; 14(13). PMC: 9268385. DOI: 10.3390/nu14132602. View

14.

Dror A, Morozov N, Daoud A, Namir Y, Yakir O, Shachar Y . Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness. PLoS One. 2022; 17(2):e0263069. PMC: 8812897. DOI: 10.1371/journal.pone.0263069. View

15.

Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Tmava Berisha A . Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020; 74(11):1498-1513. PMC: 7091696. DOI: 10.1038/s41430-020-0558-y. View

16.

Sabico S, Enani M, Sheshah E, Aljohani N, Aldisi D, Alotaibi N . Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial. Nutrients. 2021; 13(7). PMC: 8308273. DOI: 10.3390/nu13072170. View

17.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

18.

Varikasuvu S, Thangappazham B, Vykunta A, Duggina P, Manne M, Raj H . COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials. Expert Rev Anti Infect Ther. 2022; 20(6):907-913. PMC: 8862170. DOI: 10.1080/14787210.2022.2035217. View

19.

DEcclesiis O, Gavioli C, Martinoli C, Raimondi S, Chiocca S, Miccolo C . Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis. PLoS One. 2022; 17(7):e0268396. PMC: 9258852. DOI: 10.1371/journal.pone.0268396. View

20.

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View